Emisphere Technologies

Nicholas J. Hart has joined Emisphere Technologies, Inc. as vice president of strategy and development. In this capacity, Mr. Hart will be responsible for the planning and commercial development aspects of the company’s Eligen technology.
   
Mr. Hart joins the company with more than 16 years of commercial experience in the pharmaceutical industry. Most recently, he was leader of the Contraception Therapy Area and a member of the corporate executive leadership team for Organon, recently acquired by Schering Plough. Also at Organon, he served as senior director/executive director of marketing of the Women’s Healthcare Franchise; director of CNS marketing, and associate director of Specialty Products. Prior to Organon, Mr. Hart held various marketing and sales positions with Novartis, Sankyo Parke Davis Pharmaceuticals, and Bristol-Myers Squibb.
   
“I am delighted Nick Hart has joined our team at Emisphere to help us commercialize our Eligen Technology, including Eligen B12,” said Michael V. Novinski, president and chief executive officer of Emisphere. “He brings a tremendous wealth of experience and a successful track record of accomplishment in the pharmaceutical industry. He has a demonstrated skill set both strategically and operationally, and I am confident that this track record will be continued at Emisphere.”